|
Wednesday, November 16, 2016
Print Current Session:
 |
|
|
Wednesday
SESSION 24:
MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE – NEW DEVELOPMENTS AND HOT TOPICS RELATING TO STENTS
Moderators:Giancarlo Biamino, MD, PhD / Kenneth Ouriel, MD, MBA
|
|
| SESSION 24 SCHEDULE | |
| 7:46 AM - 7:51 AM | The Best Special Wires, Sheaths, Catheters And Balloons For Treating Perimalleolar And Pedal Occlusive Lesions: What’s New In Tools For Crossing Total Occlusions |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| THE SUPERA BIOMIMETIC INTERWOVEN STENT | |
| 7:52 AM - 7:57 AM | 5-Year Results With The Supera Stent Are Better Than Those With Bare Metal Stents (BMSs) And Drug Coated Balloons (DCBs) In A Propensity Matched Analysis |
| Presenter(s):Dierk Scheinert, MD / Andrej Schmidt, MD / Sabine Steiner, MD | |
| View Slides in PDF | |
| 7:58 AM - 8:03 AM | Economic Considerations With The Supera Stent For Treating SFA Lesions: How Does It Compare With Plain Old Balloon Angioplasty (POBA), BMSs, Drug Eluting Stents (DESs) And Drug Coated Balloons (DCBs) |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 8:04 AM - 8:09 AM | Supera Stenting Of Lesions Seem To Restore Distal Blood Flow Better Than Other Endovascular Treatments And As Well As A Bypass |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| THE ZILVER PTX DES | |
| 8:10 AM - 8:15 AM | New Findings From The RCT Of The Zilver PTX Stent vs. PTA And Bare Metal Stents: Interesting Findings From Subanalyses And 5-Year Result Show Widening Benefits From The DES |
| Presenter(s):Gary M. Ansel, MD / Michael D. Dake, MD | |
| View Slides in PDF | |
| 8:16 AM - 8:21 AM | RCT Comparing Zilver PTX DES And Surgical Bypass For Long Fempop Lesions Suggest Better Results In The DES Arm: Is It Due To Differences In The Method Of Patency Assessment: The ZILVERPASS Trial |
| Presenter(s):Koen Deloose, MD / Marc Bosiers, MD / Patrick Peeters, MD | |
| View Slides in PDF | |
| 8:22 AM - 8:27 AM | Update On The 2-Year Results Of The Eluvia DES From Boston Scientific For SFA Lesions: Why Are The Results So Superior To POBA: From The MAJESTIC Trial: What Is Happening With The IMPERIAL Trial Comparing Eluvia And Zilver PTX DESs |
| Presenter(s):Stefan Müller-Hülsbeck, MD | |
| View Slides in PDF | |
| BIORESORBABLE STENTS | |
| 8:28 AM - 8:33 AM | Favorable 1-2 Year Results With The Abbott Balloon Expandable Bioresorbable Drug Eluting Stent For BTK Occlusive Lesions: Do The Lesions Regress: The ABSORB BTK Trial |
| Presenter(s):Ramon L. Varcoe, MS, PhD, FRACS | |
| View Slides in PDF | |
| 8:34 AM - 8:39 AM | Status Of Other Bioabsorbable Scaffolds (Stents) For Treating Peripheral Arterial Lesions Including 3-Year Results Of The ESPRIT Trial |
| Presenter(s):Johannes Lammer, MD | |
| View Slides in PDF | |
| DESS BELOW-THE-KNEE | |
| 8:40 AM - 8:45 AM | DESs (Sirolimus) Are Better Than POBA For Treating CLI Caused By Infrapopliteal Lesions: Wound Healing And Quality Of Life Are Improved: The ACHILLES Trial |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 8:46 AM - 8:51 AM | 3 RCTs Show That DESs Have Value In Treating Long And Short BTK Occlusive Lesions: When Should They Be Used: A US Perspective |
| Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
| View Slides in PDF | |
| 8:52 AM - 8:58 AM | Panel Discussion |
| END OF SESSION 24 | |
| previous | next |